VANGUARD: Investigational mAb Effectively, Safely Prevented Hereditary Angioedema Attacks
VANGUARD: Investigational mAb Effectively, Safely Prevented Hereditary Angioedema Attacks is organized by Projects In Knowledge Inc. (PIK).
Release Date: 2023-03-09
Termination Date: 2024-03-09
Program Overview:
Among the many issues clinicians face today, staying current with advances in medicine is becoming a major challenge. MEDBrief® articles will allow clinicians to stay up-to-date and assimilate new information into their daily practice. The content of these MEDBrief® articles has been validated through an independent expert peer review process.
Activity Goal:
• The goal of this CME/CE activity is to provide comprehensive and up-to-date information on the best practices in hereditary angioedema
Learning Objectives:
Assess implications of this MEDBrief® news report for the practice setting.